Genfleet Therapeutics (Shanghai) Inc. has scheduled an extraordinary general meeting on February 9, 2026, at its location in the Shanghai Pilot Free Trade Zone. During the meeting, shareholders will consider and vote on several special resolutions, including the proposed adoption of the H Share Option Scheme, the proposed adoption of the H Share Incentive Scheme, the proposed Scheme Limit, and the proposed Service Provider Sublimit.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genfleet Therapeutics (Shanghai) Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260123-11999213), on January 22, 2026, and is solely responsible for the information contained therein.